The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biopharmaceutical 3PL Market Research Report 2025
Synopsis
Third party logistics providers (3PLs) do not own the inventory but rather act as the agent for the inventory owner. A 3PL arranges for the storage, transportation and logistics of the specialty drugs.
The global Biopharmaceutical 3PL market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical 3PL, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical 3PL.
Report Scope
The Biopharmaceutical 3PL market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical 3PL market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical 3PL companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FedEx.
DHL International GmbH
SF Express
United Parcel Service of America, Inc.
AmerisourceBergen Corporation
DB Schenker
KUEHNE + NAGEL
Kerry Logistics Network Limited
Agility
EMS
SF Express
Jd.Com, Inc.
Segment by Type
Cold Chain
Non-cold Chain
Segment by Application
Transportation
Warehousing and Storage
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical 3PL companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Third party logistics providers (3PLs) do not own the inventory but rather act as the agent for the inventory owner. A 3PL arranges for the storage, transportation and logistics of the specialty drugs.
The global Biopharmaceutical 3PL market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical 3PL, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical 3PL.
Report Scope
The Biopharmaceutical 3PL market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical 3PL market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical 3PL companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FedEx.
DHL International GmbH
SF Express
United Parcel Service of America, Inc.
AmerisourceBergen Corporation
DB Schenker
KUEHNE + NAGEL
Kerry Logistics Network Limited
Agility
EMS
SF Express
Jd.Com, Inc.
Segment by Type
Cold Chain
Non-cold Chain
Segment by Application
Transportation
Warehousing and Storage
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical 3PL companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical 3PL Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cold Chain
1.2.3 Non-cold Chain
1.3 Market by Application
1.3.1 Global Biopharmaceutical 3PL Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Transportation
1.3.3 Warehousing and Storage
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical 3PL Market Perspective (2019-2030)
2.2 Biopharmaceutical 3PL Growth Trends by Region
2.2.1 Global Biopharmaceutical 3PL Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biopharmaceutical 3PL Historic Market Size by Region (2019-2024)
2.2.3 Biopharmaceutical 3PL Forecasted Market Size by Region (2025-2030)
2.3 Biopharmaceutical 3PL Market Dynamics
2.3.1 Biopharmaceutical 3PL Industry Trends
2.3.2 Biopharmaceutical 3PL Market Drivers
2.3.3 Biopharmaceutical 3PL Market Challenges
2.3.4 Biopharmaceutical 3PL Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical 3PL Players by Revenue
3.1.1 Global Top Biopharmaceutical 3PL Players by Revenue (2019-2024)
3.1.2 Global Biopharmaceutical 3PL Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceutical 3PL Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical 3PL Revenue
3.4 Global Biopharmaceutical 3PL Market Concentration Ratio
3.4.1 Global Biopharmaceutical 3PL Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical 3PL Revenue in 2023
3.5 Biopharmaceutical 3PL Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical 3PL Product Solution and Service
3.7 Date of Enter into Biopharmaceutical 3PL Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical 3PL Breakdown Data by Type
4.1 Global Biopharmaceutical 3PL Historic Market Size by Type (2019-2024)
4.2 Global Biopharmaceutical 3PL Forecasted Market Size by Type (2025-2030)
5 Biopharmaceutical 3PL Breakdown Data by Application
5.1 Global Biopharmaceutical 3PL Historic Market Size by Application (2019-2024)
5.2 Global Biopharmaceutical 3PL Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biopharmaceutical 3PL Market Size (2019-2030)
6.2 North America Biopharmaceutical 3PL Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biopharmaceutical 3PL Market Size by Country (2019-2024)
6.4 North America Biopharmaceutical 3PL Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical 3PL Market Size (2019-2030)
7.2 Europe Biopharmaceutical 3PL Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biopharmaceutical 3PL Market Size by Country (2019-2024)
7.4 Europe Biopharmaceutical 3PL Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical 3PL Market Size (2019-2030)
8.2 Asia-Pacific Biopharmaceutical 3PL Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Region (2019-2024)
8.4 Asia-Pacific Biopharmaceutical 3PL Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical 3PL Market Size (2019-2030)
9.2 Latin America Biopharmaceutical 3PL Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biopharmaceutical 3PL Market Size by Country (2019-2024)
9.4 Latin America Biopharmaceutical 3PL Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical 3PL Market Size (2019-2030)
10.2 Middle East & Africa Biopharmaceutical 3PL Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Country (2019-2024)
10.4 Middle East & Africa Biopharmaceutical 3PL Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FedEx.
11.1.1 FedEx. Company Detail
11.1.2 FedEx. Business Overview
11.1.3 FedEx. Biopharmaceutical 3PL Introduction
11.1.4 FedEx. Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.1.5 FedEx. Recent Development
11.2 DHL International GmbH
11.2.1 DHL International GmbH Company Detail
11.2.2 DHL International GmbH Business Overview
11.2.3 DHL International GmbH Biopharmaceutical 3PL Introduction
11.2.4 DHL International GmbH Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.2.5 DHL International GmbH Recent Development
11.3 SF Express
11.3.1 SF Express Company Detail
11.3.2 SF Express Business Overview
11.3.3 SF Express Biopharmaceutical 3PL Introduction
11.3.4 SF Express Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.3.5 SF Express Recent Development
11.4 United Parcel Service of America, Inc.
11.4.1 United Parcel Service of America, Inc. Company Detail
11.4.2 United Parcel Service of America, Inc. Business Overview
11.4.3 United Parcel Service of America, Inc. Biopharmaceutical 3PL Introduction
11.4.4 United Parcel Service of America, Inc. Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.4.5 United Parcel Service of America, Inc. Recent Development
11.5 AmerisourceBergen Corporation
11.5.1 AmerisourceBergen Corporation Company Detail
11.5.2 AmerisourceBergen Corporation Business Overview
11.5.3 AmerisourceBergen Corporation Biopharmaceutical 3PL Introduction
11.5.4 AmerisourceBergen Corporation Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.5.5 AmerisourceBergen Corporation Recent Development
11.6 DB Schenker
11.6.1 DB Schenker Company Detail
11.6.2 DB Schenker Business Overview
11.6.3 DB Schenker Biopharmaceutical 3PL Introduction
11.6.4 DB Schenker Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.6.5 DB Schenker Recent Development
11.7 KUEHNE + NAGEL
11.7.1 KUEHNE + NAGEL Company Detail
11.7.2 KUEHNE + NAGEL Business Overview
11.7.3 KUEHNE + NAGEL Biopharmaceutical 3PL Introduction
11.7.4 KUEHNE + NAGEL Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.7.5 KUEHNE + NAGEL Recent Development
11.8 Kerry Logistics Network Limited
11.8.1 Kerry Logistics Network Limited Company Detail
11.8.2 Kerry Logistics Network Limited Business Overview
11.8.3 Kerry Logistics Network Limited Biopharmaceutical 3PL Introduction
11.8.4 Kerry Logistics Network Limited Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.8.5 Kerry Logistics Network Limited Recent Development
11.9 Agility
11.9.1 Agility Company Detail
11.9.2 Agility Business Overview
11.9.3 Agility Biopharmaceutical 3PL Introduction
11.9.4 Agility Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.9.5 Agility Recent Development
11.10 EMS
11.10.1 EMS Company Detail
11.10.2 EMS Business Overview
11.10.3 EMS Biopharmaceutical 3PL Introduction
11.10.4 EMS Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.10.5 EMS Recent Development
11.11 SF Express
11.11.1 SF Express Company Detail
11.11.2 SF Express Business Overview
11.11.3 SF Express Biopharmaceutical 3PL Introduction
11.11.4 SF Express Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.11.5 SF Express Recent Development
11.12 Jd.Com, Inc.
11.12.1 Jd.Com, Inc. Company Detail
11.12.2 Jd.Com, Inc. Business Overview
11.12.3 Jd.Com, Inc. Biopharmaceutical 3PL Introduction
11.12.4 Jd.Com, Inc. Revenue in Biopharmaceutical 3PL Business (2019-2024)
11.12.5 Jd.Com, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Biopharmaceutical 3PL Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cold Chain
Table 3. Key Players of Non-cold Chain
Table 4. Global Biopharmaceutical 3PL Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Biopharmaceutical 3PL Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Biopharmaceutical 3PL Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Biopharmaceutical 3PL Market Share by Region (2019-2024)
Table 8. Global Biopharmaceutical 3PL Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Biopharmaceutical 3PL Market Share by Region (2025-2030)
Table 10. Biopharmaceutical 3PL Market Trends
Table 11. Biopharmaceutical 3PL Market Drivers
Table 12. Biopharmaceutical 3PL Market Challenges
Table 13. Biopharmaceutical 3PL Market Restraints
Table 14. Global Biopharmaceutical 3PL Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Biopharmaceutical 3PL Market Share by Players (2019-2024)
Table 16. Global Top Biopharmaceutical 3PL Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical 3PL as of 2023)
Table 17. Ranking of Global Top Biopharmaceutical 3PL Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Biopharmaceutical 3PL Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biopharmaceutical 3PL Product Solution and Service
Table 21. Date of Enter into Biopharmaceutical 3PL Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biopharmaceutical 3PL Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Biopharmaceutical 3PL Revenue Market Share by Type (2019-2024)
Table 25. Global Biopharmaceutical 3PL Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Biopharmaceutical 3PL Revenue Market Share by Type (2025-2030)
Table 27. Global Biopharmaceutical 3PL Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Biopharmaceutical 3PL Revenue Market Share by Application (2019-2024)
Table 29. Global Biopharmaceutical 3PL Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Biopharmaceutical 3PL Revenue Market Share by Application (2025-2030)
Table 31. North America Biopharmaceutical 3PL Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Biopharmaceutical 3PL Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Biopharmaceutical 3PL Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Biopharmaceutical 3PL Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Biopharmaceutical 3PL Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Biopharmaceutical 3PL Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Biopharmaceutical 3PL Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Biopharmaceutical 3PL Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Biopharmaceutical 3PL Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biopharmaceutical 3PL Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Biopharmaceutical 3PL Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Biopharmaceutical 3PL Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Biopharmaceutical 3PL Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Biopharmaceutical 3PL Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Biopharmaceutical 3PL Market Size by Country (2025-2030) & (US$ Million)
Table 46. FedEx. Company Detail
Table 47. FedEx. Business Overview
Table 48. FedEx. Biopharmaceutical 3PL Product
Table 49. FedEx. Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 50. FedEx. Recent Development
Table 51. DHL International GmbH Company Detail
Table 52. DHL International GmbH Business Overview
Table 53. DHL International GmbH Biopharmaceutical 3PL Product
Table 54. DHL International GmbH Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 55. DHL International GmbH Recent Development
Table 56. SF Express Company Detail
Table 57. SF Express Business Overview
Table 58. SF Express Biopharmaceutical 3PL Product
Table 59. SF Express Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 60. SF Express Recent Development
Table 61. United Parcel Service of America, Inc. Company Detail
Table 62. United Parcel Service of America, Inc. Business Overview
Table 63. United Parcel Service of America, Inc. Biopharmaceutical 3PL Product
Table 64. United Parcel Service of America, Inc. Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 65. United Parcel Service of America, Inc. Recent Development
Table 66. AmerisourceBergen Corporation Company Detail
Table 67. AmerisourceBergen Corporation Business Overview
Table 68. AmerisourceBergen Corporation Biopharmaceutical 3PL Product
Table 69. AmerisourceBergen Corporation Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 70. AmerisourceBergen Corporation Recent Development
Table 71. DB Schenker Company Detail
Table 72. DB Schenker Business Overview
Table 73. DB Schenker Biopharmaceutical 3PL Product
Table 74. DB Schenker Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 75. DB Schenker Recent Development
Table 76. KUEHNE + NAGEL Company Detail
Table 77. KUEHNE + NAGEL Business Overview
Table 78. KUEHNE + NAGEL Biopharmaceutical 3PL Product
Table 79. KUEHNE + NAGEL Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 80. KUEHNE + NAGEL Recent Development
Table 81. Kerry Logistics Network Limited Company Detail
Table 82. Kerry Logistics Network Limited Business Overview
Table 83. Kerry Logistics Network Limited Biopharmaceutical 3PL Product
Table 84. Kerry Logistics Network Limited Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 85. Kerry Logistics Network Limited Recent Development
Table 86. Agility Company Detail
Table 87. Agility Business Overview
Table 88. Agility Biopharmaceutical 3PL Product
Table 89. Agility Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 90. Agility Recent Development
Table 91. EMS Company Detail
Table 92. EMS Business Overview
Table 93. EMS Biopharmaceutical 3PL Product
Table 94. EMS Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 95. EMS Recent Development
Table 96. SF Express Company Detail
Table 97. SF Express Business Overview
Table 98. SF Express Biopharmaceutical 3PL Product
Table 99. SF Express Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 100. SF Express Recent Development
Table 101. Jd.Com, Inc. Company Detail
Table 102. Jd.Com, Inc. Business Overview
Table 103. Jd.Com, Inc. Biopharmaceutical 3PL Product
Table 104. Jd.Com, Inc. Revenue in Biopharmaceutical 3PL Business (2019-2024) & (US$ Million)
Table 105. Jd.Com, Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical 3PL Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biopharmaceutical 3PL Market Share by Type: 2023 VS 2030
Figure 3. Cold Chain Features
Figure 4. Non-cold Chain Features
Figure 5. Global Biopharmaceutical 3PL Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Biopharmaceutical 3PL Market Share by Application: 2023 VS 2030
Figure 7. Transportation Case Studies
Figure 8. Warehousing and Storage Case Studies
Figure 9. Others Case Studies
Figure 10. Biopharmaceutical 3PL Report Years Considered
Figure 11. Global Biopharmaceutical 3PL Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Biopharmaceutical 3PL Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Biopharmaceutical 3PL Market Share by Region: 2023 VS 2030
Figure 14. Global Biopharmaceutical 3PL Market Share by Players in 2023
Figure 15. Global Top Biopharmaceutical 3PL Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical 3PL as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical 3PL Revenue in 2023
Figure 17. North America Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Biopharmaceutical 3PL Market Share by Country (2019-2030)
Figure 19. United States Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Biopharmaceutical 3PL Market Share by Country (2019-2030)
Figure 23. Germany Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Biopharmaceutical 3PL Market Share by Region (2019-2030)
Figure 31. China Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Biopharmaceutical 3PL Market Share by Country (2019-2030)
Figure 39. Mexico Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Biopharmaceutical 3PL Market Share by Country (2019-2030)
Figure 43. Turkey Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Biopharmaceutical 3PL Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. FedEx. Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 46. DHL International GmbH Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 47. SF Express Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 48. United Parcel Service of America, Inc. Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 49. AmerisourceBergen Corporation Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 50. DB Schenker Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 51. KUEHNE + NAGEL Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 52. Kerry Logistics Network Limited Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 53. Agility Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 54. EMS Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 55. SF Express Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 56. Jd.Com, Inc. Revenue Growth Rate in Biopharmaceutical 3PL Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
